Following a third report of fatal disseminated vaccine strain varicella-zoster virus infection following Zostavax administration, the Therapeutic Goods Administration (TGA) is reminding health professionals that Zostavax should not be used in people with compromised immune function.

Further details on the alert can be seen here:

Zostavax vaccine: Safety advisory

For more information on Zostavax® and access to the Zostavax® GP decision aid please review the MVEC pages below:

एमवीईसी: दाद

एमवीईसी: Zoster vaccine (Zostavax®) FAQ’s